Vernon Bernardino


FBR Reiterates Bullish Stance On Aurinia Pharmaceuticals Inc (AUPH) Following Development Updates

In a research report released Friday, FBR analyst Vernon Bernardino reiterated an Outperform rating on shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) with a …

FBR Boosts Price Target For Aurinia Pharmaceuticals Inc (AUPH) As Balance Sheet Improves

FBR analyst Vernon Bernardino, one of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) biggest bulls, is out today with a research note on AUPH, after the drug …

Aurinia Pharmaceuticals Inc (AUPH): A Hot Acquisition Target in 2017

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares are surging 18% today following fourth-quarter and full year 2016 financial results released Thursday evening that have since …

Aurinia Pharmaceuticals Inc (AUPH) Shares Continue to Soar as Voclosporin Success Opens Partnership Possibilities

  Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares have been skyrocketing following the biotech firm’s major success with its Phase IIb trial evaluating voclosporin (VCS) …

FBR Envisions Bullish Forecast for Aurinia Pharmaceuticals Inc (AUPH) Under New CEO

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) announced on Monday that Richard Glickman would be taking on new roles as chairman and CEO of the firm …

FBR Downgrades Galena Biopharma Inc (GALE) Right as Stock Skyrockets 30%

This morning, the firm revealed an independent group of experts has judged its breast cancer combination treatment of NeuVax with chemotherapy drug trastuzumab in …

FBR Optimistic on Novavax, Inc. (NVAX) Following Management Meeting

FBR analyst Vernon Bernardino met with Novavax, Inc. (NASDAQ:NVAX) management last week to discuss fundamentals and future 2017 clinical development.

FBR Offers Commentary on Aurinia Pharmaceuticals Inc (AUPH) Following Receipt of FDA Meeting Minutes

FBR analyst Vernon Bernardino came out with some commentary on Aurinia Pharmaceuticals Inc (NASDAQ:AUPH), after the drug maker announced it received meeting minutes for …

FBR Analyst Adjusts Price Target for Galena Biopharma Inc (GALE) Post Reverse Stock Split

In a research report released Friday, FBR analyst Vernon Bernardino reiterated an Outperform rating on shares of Galena Biopharma Inc (NASDAQ:GALE), while adjusting …

FBR Chimes in on Novavax, Inc. (NVAX) Following Analyst Day

In a research report released Friday, FBR Capital analyst Vernon Bernardino reiterated an Outperform rating on shares of Novavax, Inc. (NASDAQ:NVAX), with a price …